Drug intelligence / Profile preview

atractylenolide I

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Atractylenolide I is a naturally occurring sesquiterpene lactone primarily isolated from the rhizomes of Atractylodes macrocephala, a traditional Chinese medicinal herb. It is one of the principal bioactive constituents of this plant and is known for diverse biological activities, including anti-inflammatory, anti-apoptotic, antioxidant, anti-coagulant, and anti-cancer effects. Mechanistically, atractylenolide I has been shown to inhibit the TLR4/MyD88/NF-κB pathway, downregulate pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, modulate macrophage polarization, and block the JAK2/STAT3 signaling cascade, resulting in apoptosis induction in cancer cells and suppression of glycolysis. It has been explored experimentally in various disease models, especially for gastrointestinal disorders, sepsis, acute liver failure, and multiple cancers, including colorectal cancer[1][2][3][5][9].

Other names
atractylenolide Iatractylenolide-1atractylenolide1atractylenolide 1AT-I
02

Targets

IRF5 (Interferon regulatory factor 5)JAK2 (Janus kinase 2)MYD88 (Myeloid differentiation primary response protein MyD88)NF-κBSTAT3 (Signal Transducer and Activator of Transcription 3)TLR4 (Toll-like receptor 4)MEK

Beyond the preview

Go deeper on atractylenolide I.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on atractylenolide I.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call